Institute for Clinical and Economic Review (ICER) to use real-world evidence (RWE) from Aetion in assessments

  • ICER has long sought data generated outside clinical trials to enhance the understanding of how medical treatments perform in the real world
  • Only 15% of clinical trials included could be feasibly replicated using currently available real-world data sources
  • “Aetion’s rapid-cycle analytics will enable us to quickly generate evidence with the needed rigor and transparency to include in our reviews”

  Pamela Bradt, MD, MPH, ICER’s Chief Scientific Officer

Click here to learn more

About SVMPharma

SVMPharma is an innovative strategic consultancy, specialising in Real-World Evidence (RWE) for the pharmaceutical industry. SVMPharma generates RWE within UK and Europe through bespoke online Real-World Treatment Evaluators, leading to successful health technology appraisal (HTA) submissions. Clinical trial programmes do not reflect real-world clinical practice and outcomes, RWE supplements and enhances clinical datasets. SVMPharma’s specialist teams focus on delivering the outcomes that matter to your brand.

For more information, please visit and contact us at

ref: NOV2020HM001